FLNA:BMV
Filana Therapeutics Inc
MX$15,92
0,00%
(0,00) 1G
5 Eki, 12:05:31 GMT-6 · MXN
search
Tüm semboller
| Sembol | Fiyat | DeÄŸiÅŸiklik | DeÄŸiÅŸiklik % |
|---|
insights_autoFLNA ile ilgili en önemli analizler oluşturuluyor...
Piy. deÄŸ.
34,76Â Mn
Ort. hacim
0,00
Ä°ÅŸlem Hacmi
0,00
52 haftalık en yüksek
MX$56,00
52 haftalık en düşük
MX$15,92
Çalışan sayısı
19
Piy. deÄŸ.
34,76Â Mn
Ort. hacim
0,00
Ä°ÅŸlem Hacmi
0,00
52 haftalık en yüksek
MX$56,00
52 haftalık en düşük
MX$15,92
Çalışan sayısı
19
Haberler
Web kaynaklarından ve haber iş ortaklarından
Simply Wall Street
·
23 dakika önce
Palo Alto Networks (PANW) Becomes Founding Partner In Critical Infrastructure Defense Program
TradingView
·
1 saat önce
Versus Systems (NASDAQ: VS) Leadership Highlights Drinkfinger Expansion and AI Approach in Stock2Me Podcast
AP News
·
37 dakika önce
Inflation worsened last month to 3.7% in sign that prices remain elevated as midterm elections near
The Arkansas Democrat-Gazette
·
47 dakika önce
Little Rock based BSR Real Estate Investment Trust shares trading on the New York Stock Exchange
Profil
Filana Therapeutics, Inc. is an American pharmaceutical company based in Austin, Texas. Currently led by President and CEO Richard Barry, Filana is working on developing simufilam to treat tuberous sclerosis complex–related epilepsy. The company previously was developing simufilam as an oral-tablet drug candidate for the treatment of Alzheimer's disease. Development of simufilam was discontinued in November 2024 after it failed to show clinical benefit in phase III clinical trials.
In June 2024, the United States Department of Justice charged an advisor to Cassava Hoau-Yan Wang, with fraud over research results related to the experimental drug. Less than a month later, the president, chief executive officer and chairman of the board, Remi Barbier, resigned along with Lindsay Burns, his wife, who was the company's senior vice president and Wang's co-author. The U.S. Securities and Exchange Commission filed fraud charges in September 2024 against Barbier, Burns and Wang. The parties did not admit wrongdoing, but agreed to pay fines of the company $40 million, Barbier $175,000, Burns $85,000, and Wang $50,000. Wikipedia
Filana Therapeutics Inc hakkında
CEO-
Çalışan Sayısı19
KuruluÅŸ Tarihi1998
Genel MerkezAustin, Teksas, Amerika BirleÅŸik Devletleri
Sektör-
Web Sitesipaintrials.com